MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

156.09B

Vuru Grade

54.36/100

Current Price

$56.39
-0.18 (-0.32%)

Growth Price

$54.41
Fairly valued

Stability Price

$20.51
Overvalued by 63.63%

Company Metrics

  • P/E 34.57
  • P/S 3.98
  • P/B 3.58
  • EPS 1.63
  • Cash ROIC 12.97%
  • Cash Ratio 0.70
  • Dividend 1.84 / 3.31 %
  • Avg. Vol. 8.84M
  • Shares 2.77B
  • Market Cap. 156.09B

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Brokerages Set Merck & Co., Inc. (NYSE:MRK) Target Price at $61.55
The Point Review - May 25, 2016
Merck & Co., Inc. (NYSE:MRK) shares traded +1.24% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $61.55 within the next 52-weeks.
Analyst Review: Merck & Company, Inc. (NYSE:MRK) - Risers & Fallers
Market Analyst's Next Quarter Revenue Target Opinions: Merck & Company, Inc ... - WsNews 4investors
Merck & Co. Inc (MRK) Closes 1.74% Up on the Day for May 25
Equities.com - May 25, 2016
Merck & Co. Inc currently has a total float of 2.77 billion shares and moves 8.33 million a day, on average. The stock opened at $55.81 on May 25 and traded between a low of $55.77 and a high of $56.67.
Merck & Co Keytruda: A Likely Blockbuster in the near Future
Business Finance News - May 17, 2016
As key players in the immuno-oncology therapeutic market move towards combination therapies to cover more ailments in multiple pathological categories, Merck & Co., Inc. (NYSE:MRK) has launched cell death-1 (PD-1) checkpoint inhibitor Keytruda ...
Key Stocks of the Day: Merck & Co. Inc. (NYSE:MRK)
The News Journal - 17 hours ago
As it reflects the theoretical cost of buying the company's shares, the market cap of Merck & Co. Inc. (NYSE:MRK) is currently rolling at 156925.18, making it one of the key stocks in today's market.
Merck & Co. Inc.: Merck Announces FDA Accepts Samsung Bioepis' Biologics ...
The Wall Street Transcript - May 24, 2016
KENILWORTH, N.J. - Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) submitted by Samsung ...
Samsung Targets US Drug Market With Remicade Knockoff - Wall Street Journal
Samsung Targets US Drug Market with Remicade Biosimilar: Smart Move? - Bidness ETC
AstraZeneca plc, Merck, AbbVie Inc: Can Generics pose a Threat?
Business Finance News - May 16, 2016
Multiple pharmaceuticals and Biotech companies such as AstraZeneca plc (NYSE:AZN), Merck & Co, and AbbVie Inc. along with others are under constant threat of generics and biosimilars to different therapeutic markets. The majority of the pharmaceutical ...
Eli Lilly and Co (NYSE:LLY) & Merck & Co., Inc. (NYSE:MRK) Healthcare Active ...
Wall Street 24 - May 25, 2016
On Tuesday, Shares of Eli Lilly and Co (NYSE:LLY) gained 1.23% to $74.99. The share price is trading in a range of $74.36 - $75.20.
Stock Earnings Review: Merck & Co., Inc. (MRK), CVS Health Corp (CVS)
Beacon Chronicle - May 23, 2016
Last Trade: The Company closed its last session at $99.46 yesterday with the loss of -1.48%. The market capitalization of the company is $105.25 Billion, with the average Volume of $4.06 Million. The stock currently has its 52-Week High range of $113 ...
Analyst's Recommendations in Limelight: Merck & Co., Inc. (NYSE:MRK)
The Point Review - May 10, 2016
Merck & Co., Inc. (NYSE:MRK) has grabbed the attention from analysts, when it saw a value increase of 0.93 percent in the last trading session.
Stock Grabbing Investor's Attention: Merck & Co., Inc. (NYSE:MRK) - CWRU Observer
Merck & Co., Inc. (MRK) Shares Gap Up on Analyst Upgrade - NewsWay 21
Two Biotech stocks to Watch: Merck & Company, Inc. (NYSE:MRK) , Array ...
Is stories - 22 hours ago
Merck & Company, Inc. (NYSE:MRK) increased +1.74% to $56.57 while traded 9.6 million shares on 5/25/2016. The stock price negotiated for value between $55.77 to $56.67 in recent trading session.